Sec Form 4 Filing - Wicki Andreas @ Pacira Pharmaceuticals, Inc. - 2013-09-11

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Wicki Andreas 2. Issuer Name and Ticker or Trading Symbol Pacira Pharmaceuticals, Inc. [ PCRX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) GOVERNORS SQUARE, SUITE 4-212-2,, 23 LIME TREE BAY AVE. WEST BAY 3. Date of Earliest Transaction (MM/DD/YY) 09/11/2013 (Street) GRAND CAYMAN, E900000 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 09/11/2013 X 37,192 A $ 2.69 1,668,136 I See footnote. ( 1 ) Common Stock 09/11/2013 S( 2 ) 2,686 D $ 37.25 1,665,450 I See footnote. ( 1 ) Common Stock 09/11/2013 X 41,841 A $ 13.44 1,707,291 I See footnote. ( 1 ) Common Stock 09/11/2013 S( 3 ) 15,097 D $ 37.25 1,692,194 I See foootnote. ( 1 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Repo rted Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrant (right to buy) $ 2.69 09/11/2013 X 37,192 01/22/2009 01/21/2014 Common Stock 37,192 $ 0 0 I See footnote. ( 1 ) Warrant (right to buy) $ 13.44 09/11/2013 X 41,841 12/29/2010 12/29/2017 Common Stock 41,841 $ 0 0 I See footnote. ( 1 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Wicki Andreas GOVERNORS SQUARE, SUITE 4-212-2, 23 LIME TREE BAY AVE. WEST BAY GRAND CAYMAN, E900000 X Signatures /s/ Mehdi Khodadad (Attorney-in-Fact) 09/12/2013 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The board of directors of HBM Healthcare Investments (Cayman) Ltd. ("HBM") has sole voting and investment power with respect to the securities held by such entity and acts by majority vote. The reporting person does not have sole voting or investment power over the securities held by HBM. However, the reporting person may be deemed to have beneficial ownership of these securities by virtue of his membership on the board of directors of HBM. The reporting person disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest herein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose of Section 16 of the Exchange Act, or for any other purpose. ( 2 )On September 11, 2013, HBM exercised a warrant to purchase 37,192 shares of the Issuer's common stock for $2.69 a share. HBM paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 2,686 of the warrant shares to pay the exercise price and issuing to HBM the remaining 34,506 shares. The Issuer also paid $7.02 to HBM in lieu of a fractional share. ( 3 )On September 11, 2013, HBM exercised a warrant to purchase 41,841 shares of the Issuer's common stock for $13.44 a share. HBM paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 15,097 of the warrant shares to pay the exercise price and issuing to HBM the remaining 26,744 shares. The Issuer also paid $20.21 to HBM in lieu of a fractional share.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.